Average Co-Inventor Count = 4.35
ph-index = 9
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Novo Nordisk A/s (21 from 1,777 patents)
2. Novo Nordick A/s (1 from 6 patents)
3. Transtech Pharma, Inc. (49 patents)
22 patents:
1. RE45183 - Heteroaryl-ureas and their use as glucokinase activators
2. 8586614 - Urea glucokinase activators
3. 8263634 - Heteroaryl-ureas and their use as glucokinase activators
4. 8148412 - Heteroaromatic glucokinase activators
5. 7999114 - Dicycloalkylcarbamoyl ureas as glucokinase activators
6. 7884210 - Ureido-thiazole glucokinase activators
7. 7872139 - Heteroaryl-ureas and their use as glucokinase activators
8. 7851636 - Heteroaryl-ureas and their use as glucokinase activators
9. 7598391 - Heteroaryl-ureas and their use as glucokinase activators
10. 7582769 - Dicycloalkyl urea glucokinase activators
11. 7235538 - Heterocyclic compounds, which are inhibitors of the enzyme DPP-IV
12. 7192952 - Heterocyclic compounds that are inhibitors of the enzyme DPP-IV
13. 6960610 - Use of glycogen phosphorylase inhibitors for treatment of cardiovascular diseases
14. 6869947 - Heterocyclic compounds that are inhibitors of the enzyme DPP-IV
15. 6590118 - Aromatic compounds